Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial Evaluating Chemotherapy Followed by Response-Based Reduced Radiation Therapy for Patients With Central Nervous System Germinomas

NCT06368817 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT06368817
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06368817 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial Evaluating Chemotherapy Followed by Response-Based Reduced Radiation Therapy for Patients With Central Nervous System Germinomas
Lead sponsor
Children's Oncology Group
Phase
Phase 2
Overall status
Recruiting
Start date
October 22, 2024
Completion date
November 4, 2033
Enrollment
240 (estimated)
Sites
115

Conditions

As the registry lists them; a condition with its own page is linked.

basal ganglia germinoma, diabetes insipidus, germinoma, pineal region germinoma, suprasellar germinoma, thalamic germinoma